For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of ANUH PHARMA. For more details, see the ANUH PHARMA quarterly results and ANUH PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.1 |
No. of shares | m | 50.11 |
1 Week | % | -7.8 |
1 Month | % | -5.5 |
1 Year | % | 156.5 |
52 week H/L | Rs | 265.0/86.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ANUH PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 190 | 170 | 437 | 166 | 110 | |
Low | Rs | 119 | 97 | 90 | 85 | 77 | |
Sales per share (Unadj.) | Rs | 128.0 | 122.5 | 86.2 | 97.1 | 105.3 | |
Earnings per share (Unadj.) | Rs | 9.3 | 5.7 | 5.7 | 6.1 | 7.2 | |
Diluted earnings per share | Rs | 4.7 | 2.9 | 5.7 | 6.1 | 7.2 | |
Cash flow per share (Unadj.) | Rs | 10.0 | 8.5 | 8.7 | 8.5 | 9.2 | |
Dividends per share (Unadj.) | Rs | 2.75 | 2.75 | 1.50 | 1.75 | 2.00 | |
Adj. dividends per share | Rs | 1.38 | 1.38 | 1.50 | 1.75 | 2.00 | |
Avg Dividend yield | % | 1.8 | 2.1 | 0.6 | 1.4 | 2.1 | |
Book value per share (Unadj.) | Rs | 65.7 | 64.7 | 38.0 | 42.7 | 48.1 | |
Adj. book value per share | Rs | 32.8 | 32.4 | 38.0 | 42.7 | 48.1 | |
Shares outstanding (eoy) | m | 25.06 | 25.06 | 50.11 | 50.11 | 50.11 | |
Price / Sales ratio | x | 1.2 | 1.1 | 3.1 | 1.3 | 0.9 | |
Avg P/E ratio | x | 16.6 | 23.4 | 46.5 | 20.6 | 12.9 | |
P/CF ratio (eoy) | x | 15.5 | 15.7 | 30.4 | 14.8 | 10.2 | |
Price / Book Value ratio | x | 2.3 | 2.1 | 6.9 | 2.9 | 1.9 | |
Dividend payout | % | 29.5 | 48.2 | 26.4 | 28.7 | 27.7 | |
Avg Mkt Cap | Rs m | 3,868 | 3,345 | 13,215 | 6,290 | 4,683 | |
Total wages/salary | Rs m | 101 | 134 | 143 | 151 | 172 |
ANUH PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,207 | 3,070 | 4,320 | 4,866 | 5,275 | |
Other income | Rs m | 47 | 42 | 105 | 52 | 61 | |
Total revenues | Rs m | 3,254 | 3,112 | 4,425 | 4,918 | 5,336 | |
Gross profit | Rs m | 300 | 232 | 451 | 475 | 518 | |
Depreciation | Rs m | 17 | 70 | 151 | 120 | 97 | |
Interest | Rs m | 6 | 13 | 20 | 16 | 7 | |
Profit before tax | Rs m | 324 | 192 | 386 | 391 | 475 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 90 | 49 | 101 | 86 | 113 | |
Profit after tax | Rs m | 234 | 143 | 284 | 306 | 362 | |
Gross profit margin | % | 9.3 | 7.6 | 10.4 | 9.8 | 9.8 | |
Effective tax rate | % | 27.9 | 25.3 | 26.2 | 21.9 | 23.8 | |
Net profit margin | % | 7.3 | 4.7 | 6.6 | 6.3 | 6.9 |
ANUH PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,522 | 2,230 | 2,377 | 2,587 | 3,076 | |
Current liabilities | Rs m | 748 | 1,627 | 1,395 | 1,309 | 1,613 | |
Net working cap to sales | % | 24.1 | 19.6 | 22.7 | 26.3 | 27.7 | |
Current ratio | x | 2.0 | 1.4 | 1.7 | 2.0 | 1.9 | |
Inventory Days | Days | 46 | 101 | 29 | 36 | 66 | |
Debtors Days | Days | 848 | 964 | 903 | 1,018 | 1,185 | |
Net fixed assets | Rs m | 872 | 1,034 | 949 | 885 | 966 | |
Share capital | Rs m | 125 | 125 | 251 | 251 | 251 | |
"Free" reserves | Rs m | 1,521 | 1,497 | 1,656 | 1,887 | 2,162 | |
Net worth | Rs m | 1,646 | 1,622 | 1,906 | 2,138 | 2,412 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 2,394 | 3,264 | 3,326 | 3,472 | 4,042 | |
Interest coverage | x | 55.2 | 16.2 | 20.0 | 25.8 | 64.6 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.3 | 0.9 | 1.3 | 1.4 | 1.3 | |
Return on assets | % | 10.0 | 4.8 | 9.2 | 9.3 | 9.1 | |
Return on equity | % | 14.2 | 8.8 | 14.9 | 14.3 | 15.0 | |
Return on capital | % | 20.0 | 12.6 | 21.3 | 19.0 | 20.0 | |
Exports to sales | % | 46.2 | 46.4 | 49.2 | 44.3 | 52.5 | |
Imports to sales | % | 68.9 | 73.1 | 67.8 | 62.1 | 53.2 | |
Exports (fob) | Rs m | 1,481 | 1,424 | 2,125 | 2,156 | 2,770 | |
Imports (cif) | Rs m | 2,210 | 2,243 | 2,927 | 3,024 | 2,808 | |
Fx inflow | Rs m | 1,481 | 1,424 | 2,125 | 2,156 | 2,770 | |
Fx outflow | Rs m | 2,210 | 2,243 | 2,927 | 3,024 | 2,808 | |
Net fx | Rs m | -729 | -820 | -802 | -868 | -38 |
ANUH PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 71 | 489 | -187 | 289 | 539 | |
From Investments | Rs m | 29 | -765 | 522 | -78 | -435 | |
From Financial Activity | Rs m | -65 | 222 | -331 | -194 | -123 | |
Net Cashflow | Rs m | 35 | -54 | 4 | 16 | -19 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Arun Todarwal | COMP SEC: Ashwini Shrikant Ambrale | YEAR OF INC: 1960 | BSE CODE: 506260 | FV (Rs): 5 | DIV YIELD (%): 0.9 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ANUH PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.